Replies to post #168951 on Biotech Values

[DewDiligence]

Maybe Levin grew tired of Teva’s incessant BS that FDA will require generic-Copaxone applicants to run safety and efficacy trials.

[DewDiligence]

TEVA—No one can cross Frost!

Soon, this won’t be a problem anymore:

http://www.sec.gov/Archives/edgar/data/818686/000119312514240099/d745034dex991.htm

…with the progress we have made, and continue to make, at Teva, I have advised the Board that I believe it will be appropriate for me to step down as Chairman approximately by the end of this year. Our Corporate Governance and Nominating Committee is working on a succession plan.